Sven Britton

7.2k total citations
152 papers, 5.7k citations indexed

About

Sven Britton is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Sven Britton has authored 152 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Infectious Diseases, 55 papers in Epidemiology and 51 papers in Immunology. Recurrent topics in Sven Britton's work include Tuberculosis Research and Epidemiology (25 papers), HIV Research and Treatment (24 papers) and Mycobacterium research and diagnosis (15 papers). Sven Britton is often cited by papers focused on Tuberculosis Research and Epidemiology (25 papers), HIV Research and Treatment (24 papers) and Mycobacterium research and diagnosis (15 papers). Sven Britton collaborates with scholars based in Sweden, Ethiopia and United States. Sven Britton's co-authors include Hannah Akuffo, A. Graham Bird, Dawit Wolday, Ronald Palacios, Daniel Eliáš, Jan Andersson, Göran Möller, Thomas Schön, Sandra M. McLachlan and P Gergely and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Sven Britton

150 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Britton Sweden 43 2.2k 2.0k 1.9k 967 708 152 5.7k
Sebastian Lucas United Kingdom 47 3.7k 1.7× 3.7k 1.8× 607 0.3× 875 0.9× 754 1.1× 206 7.6k
Jonathan Gold United States 37 2.3k 1.1× 2.9k 1.4× 967 0.5× 563 0.6× 810 1.1× 80 5.6k
David Nadal Switzerland 43 1.6k 0.7× 2.1k 1.1× 1.2k 0.6× 530 0.5× 1.5k 2.1× 220 5.9k
Dana G. Wolf Israel 42 1.9k 0.9× 3.4k 1.7× 1.5k 0.8× 422 0.4× 879 1.2× 159 6.6k
Anton M. van Loon Netherlands 47 2.9k 1.3× 4.9k 2.4× 713 0.4× 475 0.5× 660 0.9× 184 7.7k
Paul‐Henri Lambert Switzerland 50 1.4k 0.6× 2.1k 1.0× 4.6k 2.4× 568 0.6× 396 0.6× 161 9.1k
Stuart E. Starr United States 45 1.7k 0.8× 4.1k 2.1× 2.1k 1.1× 601 0.6× 422 0.6× 140 6.5k
J Convit Venezuela 41 1.9k 0.9× 3.0k 1.5× 1.8k 0.9× 591 0.6× 242 0.3× 212 6.3k
Joseph D. Schwartzman United States 41 1.1k 0.5× 2.3k 1.1× 919 0.5× 1.9k 1.9× 231 0.3× 95 5.4k
Adriana Weinberg United States 45 1.2k 0.5× 4.3k 2.1× 1.5k 0.8× 453 0.5× 526 0.7× 234 6.3k

Countries citing papers authored by Sven Britton

Since Specialization
Citations

This map shows the geographic impact of Sven Britton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Britton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Britton more than expected).

Fields of papers citing papers by Sven Britton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Britton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Britton. The network helps show where Sven Britton may publish in the future.

Co-authorship network of co-authors of Sven Britton

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Britton. A scholar is included among the top collaborators of Sven Britton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Britton. Sven Britton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Tushar, Ekamol Tantisattamo, John P. Gibson, et al.. (2017). Feasibility of BK Virus Real-Time PCR Testing in Renal Graft Biopsies With Negative SV40 Staining. Transplantation Proceedings. 49(6). 1294–1300. 4 indexed citations
2.
Ekermo, Bengt, et al.. (2012). Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden. Scandinavian Journal of Infectious Diseases. 44(11). 852–859. 15 indexed citations
3.
Tasew, Geremew, Susanne Nylén, Nicolas Ruffin, et al.. (2010). Systemic FasL and TRAIL Neutralisation Reduce Leishmaniasis Induced Skin Ulceration. PLoS neglected tropical diseases. 4(10). e844–e844. 29 indexed citations
4.
Bochud, Pierre–Yves, Daniel Sinsimer, Alan Aderem, et al.. (2009). Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy. European Journal of Clinical Microbiology & Infectious Diseases. 28(9). 1055–1065. 62 indexed citations
5.
Eliáš, Daniel, Getahun Mengistu, Hannah Akuffo, & Sven Britton. (2006). Are intestinal helminths risk factors for developing active tuberculosis?. Tropical Medicine & International Health. 11(4). 551–558. 111 indexed citations
6.
Akuffo, Hannah, et al.. (2005). Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clinical & Experimental Immunology. 139(3). 398–404. 70 indexed citations
7.
Wolday, Dawit, et al.. (2005). Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: Relation to RNA copy number and CD4 T-cell count. Journal of Medical Virology. 78(2). 161–168. 13 indexed citations
8.
Schön, Thomas, Feleke Moges, Endalkachew Belayneh Melese, et al.. (2003). Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. European Respiratory Journal. 21(3). 483–488. 63 indexed citations
9.
Yassin, Mohammed A., Joseph Olobo, Dawit Kidane, et al.. (2003). Diagnosis of Tuberculous Lymphadenitis in Butajira, Rural Ethiopia. Scandinavian Journal of Infectious Diseases. 35(4). 240–243. 35 indexed citations
11.
Berhe, Nega, Dawit Wolday, Asrat Hailu, et al.. (1999). HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS. 13(14). 1921–1925. 65 indexed citations
12.
Larsson, Sten, Graham Hotchkiss, Jin Su, et al.. (1996). A Novel Ribozyme Target Site Located in the HIV-1NefOpen Reading Frame. Virology. 219(1). 161–169. 22 indexed citations
13.
Jacobsson, Bengt, et al.. (1991). Intracellular Metabolism of 3′-Azidothymidine in Isolated Human Peripheral Blood Mononuclear Cells. AIDS Research and Human Retroviruses. 7(9). 751–759. 61 indexed citations
14.
Tozzi, Valerio, Sven Britton, A. Ehrnst, Rodiça Lenkei, & Örjan Strannegård. (1989). Persistent productive HIV infection in EBV‐transformed B lymphocytes. Journal of Medical Virology. 27(1). 19–24. 22 indexed citations
15.
Akuffo, Hannah, Thomas E. Fehniger, & Sven Britton. (1988). Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression.. The Journal of Immunology. 141(7). 2461–2466. 33 indexed citations
16.
Andersson, Jan, Birgit Sköldenberg, Werner Henle, et al.. (1987). Acyclovir treatment in infectious mononucleosis: A clinical and virological study. Infection. 15(S1). S14–S20. 43 indexed citations
17.
Britton, Sven, et al.. (1985). Chest physiotherapy in primary pneumonia.. BMJ. 290(6483). 1703–1704. 57 indexed citations
18.
Martı́nez-Maza, Otoniel & Sven Britton. (1983). Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen.. The Journal of Experimental Medicine. 157(6). 1808–1814. 51 indexed citations
19.
Bird, A. Graham, Sven Britton, Ingemar Ernberg, & Kenneth Nilsson. (1981). Characteristics of Epstein-Barr virus activation of human B lymphocytes.. The Journal of Experimental Medicine. 154(3). 832–839. 62 indexed citations
20.
Britton, Sven. (1969). REGULATION OF ANTIBODY SYNTHESIS AGAINST ESCHERICHIA COLI ENDOTOXIN. The Journal of Experimental Medicine. 129(3). 469–482. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026